Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 6
2010 2
2011 8
2012 13
2013 4
2014 13
2015 6
2016 10
2017 3
2018 2
2019 3
2020 12
2021 12
2022 20
2023 37
2024 47
2025 43

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Results by year

Filters applied: . Clear all
Page 1
Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: A multicenter retrospective study.
Avallone G, Mastorino L, Tavoletti G, Macagno N, Barei F, Schena D, Rossi M, Magnaterra E, Antonelli F, Babino G, Viola R, Gargiulo L, Conforti C, Rapparini L, Errichetti E, Patruno C, Ruggiero P, Roccuzzo G, Maronese CA, Girolomoni G, Gola M, Chiricozzi A, Balato A, Ambrogio F, Narcisi A, Zalaudek I, Gurioli C, Napolitano M, Marzano AV, Foti C, Costanzo A, Piraccini BM, Ferrucci SM, Ortoncelli M, Quaglino P, Ribero S. Avallone G, et al. Among authors: narcisi a. J Am Acad Dermatol. 2024 May;90(5):1031-1034. doi: 10.1016/j.jaad.2024.01.004. Epub 2024 Jan 9. J Am Acad Dermatol. 2024. PMID: 38199282 No abstract available.
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Mercuri SR, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: narcisi a. Front Immunol. 2024 Jan 11;14:1341708. doi: 10.3389/fimmu.2023.1341708. eCollection 2023. Front Immunol. 2024. PMID: 38274801 Free PMC article.
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: narcisi a. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
Chronic Hand Eczema (CHE): A Narrative Review.
Ghezzi G, Falcidia C, Paolino G, Mercuri SR, Narcisi A, Costanzo A, Valenti M. Ghezzi G, et al. Among authors: narcisi a. Dermatol Ther (Heidelb). 2025 Apr;15(4):771-795. doi: 10.1007/s13555-025-01365-7. Epub 2025 Mar 10. Dermatol Ther (Heidelb). 2025. PMID: 40064754 Free PMC article. Review.
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Barei F, Macchi S, Calzari P, Ribero S, Ortoncelli M, Foti C, Balato A, Di Brizzi EV, Peris K, Gori N, Ippoliti E, Gurioli C, Piraccini BM, Trave I, Cozzani E, Pezzolo E, Bonzano L, Errichetti E, Schettini N, Nettis E, Gola M, Milanesi N, Feliciani C, De Felici Del Giudice MB, Campanati A, Gioacchini H, Pisapia A, Avallone G, Micali G, Musumeci ML, Ortega R, Manzo Margiotta F, Romanelli M, Hansel K, Stingeni L, Patruno C, Esposito M, Fargnoli MC, De Berardinis A, Ferreli C, Calabrese L, Rubegni P, Lazzeri L, Grigolato L, Galli B, Rossi M, Maurelli M, Girolomoni G, Lauletta G, Napolitano M, Alfano A, Gargiulo L, Narcisi A, Marzano AV, Ferrucci SM. Barei F, et al. Among authors: narcisi a. Clin Exp Dermatol. 2025 Oct 27;50(11):2221-2231. doi: 10.1093/ced/llaf275. Clin Exp Dermatol. 2025. PMID: 40578600
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study.
Vignoli CA, Gargiulo L, Ibba L, Balato A, Barbareschi M, Barruscotti S, Bazzacco G, Bellinato F, Bianchi VG, Boccaletti V, Caposiena Caro RD, Ferrucci SM, Fraghì A, Fulgione E, Gallo G, Gisondi P, Giunipero di Corteranzo I, Malagoli P, Marzano AV, Mercuri SR, Orsini D, Quaglino P, Ribero S, Costanzo A, Narcisi A. Vignoli CA, et al. Among authors: narcisi a. J Dermatolog Treat. 2025 Dec;36(1):2444494. doi: 10.1080/09546634.2024.2444494. Epub 2025 Jan 6. J Dermatolog Treat. 2025. PMID: 39761973 Free article.
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis.
Amerio P, Ferrucci SM, Galluzzo M, Napolitano M, Narcisi A, Levi A, Di Fino S, Palladino C, Patruno C, Rossi M. Amerio P, et al. Among authors: narcisi a. Dermatol Ther (Heidelb). 2024 Jun;14(6):1443-1455. doi: 10.1007/s13555-024-01185-1. Epub 2024 May 30. Dermatol Ther (Heidelb). 2024. PMID: 38811470 Free PMC article. Review.
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.
Narcisi A, Di Lernia V, Esposito M, Forte V, Ferrucci SM, Gerratana L, Morrone P, Muscoli S, Napolitano M, Ortoncelli M, Talamonti M. Narcisi A, et al. Dermatol Ther (Heidelb). 2025 May;15(5):1063-1078. doi: 10.1007/s13555-025-01391-5. Epub 2025 Mar 31. Dermatol Ther (Heidelb). 2025. PMID: 40164817 Free PMC article. Review.
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis).
Gargiulo L, Ibba L, Alfano A, Malagoli P, Amoruso F, Balato A, Barei F, Burroni AG, Caccavale S, Calzavara-Pinton P, Esposito M, Fargnoli MC, Ferrucci SM, Foti C, Girolomoni G, Gola M, Guanti MB, Gurioli C, Magliulo M, Maurelli M, Morrone P, Musumeci ML, Napolitano M, Ortoncelli M, Patruno C, Piraccini BM, Pezzolo E, Ribero S, Rossi M, Savoia P, Sciarrone C, Tirone B, Vaccino M, Veronese F, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: narcisi a. J Dermatolog Treat. 2024 Dec;35(1):2411855. doi: 10.1080/09546634.2024.2411855. Epub 2024 Oct 10. J Dermatolog Treat. 2024. PMID: 39389612 Free article.
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis).
Valenti M, Ibba L, Di Giulio S, Gargiulo L, Malagoli P, Balato A, Carrera CG, Dapavo P, Di Brizzi EV, Dini V, Gaiani F, Loconsole F, Marzano AV, Megna M, Michelucci A, Potestio L, Ribero S, Costanzo A, Narcisi A. Valenti M, et al. Among authors: narcisi a. J Dermatolog Treat. 2025 Dec;36(1):2456532. doi: 10.1080/09546634.2025.2456532. Epub 2025 Jan 27. J Dermatolog Treat. 2025. PMID: 39870384 Free article.
203 results